nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CHRM3—ureter—uterine cancer	0.0645	0.399	CbGeAlD
Solifenacin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0493	0.463	CbGbCtD
Solifenacin—CHRM3—muscle of abdomen—uterine cancer	0.0464	0.288	CbGeAlD
Solifenacin—CYP3A4—Progesterone—uterine cancer	0.0327	0.307	CbGbCtD
Solifenacin—CYP3A4—Etoposide—uterine cancer	0.0146	0.137	CbGbCtD
Solifenacin—Benazepril—MTHFR—uterine cancer	0.0135	1	CrCbGaD
Solifenacin—CHRM3—exocrine gland—uterine cancer	0.0127	0.0787	CbGeAlD
Solifenacin—CYP3A4—Doxorubicin—uterine cancer	0.00997	0.0936	CbGbCtD
Solifenacin—CHRM5—epithelium—uterine cancer	0.00988	0.0612	CbGeAlD
Solifenacin—CHRM3—smooth muscle tissue—uterine cancer	0.00533	0.033	CbGeAlD
Solifenacin—CHRM3—renal system—uterine cancer	0.00513	0.0317	CbGeAlD
Solifenacin—CHRM1—female reproductive system—uterine cancer	0.00459	0.0284	CbGeAlD
Solifenacin—CHRM3—female reproductive system—uterine cancer	0.00411	0.0254	CbGeAlD
Solifenacin—CHRM3—female gonad—uterine cancer	0.00374	0.0231	CbGeAlD
Solifenacin—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00325	0.00453	CcSEcCtD
Solifenacin—Ileus—Epirubicin—uterine cancer	0.00321	0.00447	CcSEcCtD
Solifenacin—Angioedema—Progesterone—uterine cancer	0.00317	0.00441	CcSEcCtD
Solifenacin—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00316	0.0044	CcSEcCtD
Solifenacin—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.00437	CcSEcCtD
Solifenacin—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00308	0.00428	CcSEcCtD
Solifenacin—Palpitations—Progesterone—uterine cancer	0.00307	0.00427	CcSEcCtD
Solifenacin—Cough—Progesterone—uterine cancer	0.00303	0.00421	CcSEcCtD
Solifenacin—Hypertension—Progesterone—uterine cancer	0.00299	0.00417	CcSEcCtD
Solifenacin—Ileus—Doxorubicin—uterine cancer	0.00297	0.00414	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00293	0.00408	CcSEcCtD
Solifenacin—Dry mouth—Progesterone—uterine cancer	0.00289	0.00402	CcSEcCtD
Solifenacin—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00287	0.004	CcSEcCtD
Solifenacin—Confusional state—Progesterone—uterine cancer	0.00285	0.00397	CcSEcCtD
Solifenacin—Anaphylactic shock—Progesterone—uterine cancer	0.00283	0.00394	CcSEcCtD
Solifenacin—CYP3A4—renal system—uterine cancer	0.00282	0.0174	CbGeAlD
Solifenacin—Infection—Progesterone—uterine cancer	0.00281	0.00391	CcSEcCtD
Solifenacin—Pharyngitis—Dactinomycin—uterine cancer	0.0028	0.00389	CcSEcCtD
Solifenacin—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00278	0.00387	CcSEcCtD
Solifenacin—Nervous system disorder—Progesterone—uterine cancer	0.00278	0.00386	CcSEcCtD
Solifenacin—Dysphonia—Epirubicin—uterine cancer	0.00277	0.00385	CcSEcCtD
Solifenacin—Tachycardia—Progesterone—uterine cancer	0.00276	0.00385	CcSEcCtD
Solifenacin—Skin disorder—Progesterone—uterine cancer	0.00275	0.00383	CcSEcCtD
Solifenacin—Erythema multiforme—Dactinomycin—uterine cancer	0.00266	0.00371	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00266	0.0037	CcSEcCtD
Solifenacin—Delirium—Epirubicin—uterine cancer	0.00265	0.00368	CcSEcCtD
Solifenacin—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00262	0.00364	CcSEcCtD
Solifenacin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00259	0.0036	CcSEcCtD
Solifenacin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.00357	CcSEcCtD
Solifenacin—Dysphonia—Doxorubicin—uterine cancer	0.00256	0.00356	CcSEcCtD
Solifenacin—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.00355	CcSEcCtD
Solifenacin—Somnolence—Progesterone—uterine cancer	0.00252	0.0035	CcSEcCtD
Solifenacin—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.0035	CcSEcCtD
Solifenacin—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0025	0.00348	CcSEcCtD
Solifenacin—Dyspepsia—Progesterone—uterine cancer	0.00249	0.00347	CcSEcCtD
Solifenacin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00249	0.00347	CcSEcCtD
Solifenacin—Decreased appetite—Progesterone—uterine cancer	0.00246	0.00343	CcSEcCtD
Solifenacin—Delirium—Doxorubicin—uterine cancer	0.00245	0.00341	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00244	0.0034	CcSEcCtD
Solifenacin—Fatigue—Progesterone—uterine cancer	0.00244	0.0034	CcSEcCtD
Solifenacin—Constipation—Progesterone—uterine cancer	0.00242	0.00337	CcSEcCtD
Solifenacin—Feeling abnormal—Progesterone—uterine cancer	0.00233	0.00325	CcSEcCtD
Solifenacin—Gastrointestinal pain—Progesterone—uterine cancer	0.00232	0.00322	CcSEcCtD
Solifenacin—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00317	CcSEcCtD
Solifenacin—Hepatocellular injury—Epirubicin—uterine cancer	0.00228	0.00317	CcSEcCtD
Solifenacin—Infestation NOS—Etoposide—uterine cancer	0.00227	0.00316	CcSEcCtD
Solifenacin—Infestation—Etoposide—uterine cancer	0.00227	0.00316	CcSEcCtD
Solifenacin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00314	CcSEcCtD
Solifenacin—CYP3A4—female reproductive system—uterine cancer	0.00226	0.014	CbGeAlD
Solifenacin—Urticaria—Progesterone—uterine cancer	0.00225	0.00313	CcSEcCtD
Solifenacin—Abdominal pain—Progesterone—uterine cancer	0.00224	0.00311	CcSEcCtD
Solifenacin—Hyperkalaemia—Epirubicin—uterine cancer	0.00224	0.00311	CcSEcCtD
Solifenacin—Renal failure—Etoposide—uterine cancer	0.00223	0.00311	CcSEcCtD
Solifenacin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.0031	CcSEcCtD
Solifenacin—Cystitis noninfective—Epirubicin—uterine cancer	0.00222	0.00309	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.00308	CcSEcCtD
Solifenacin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.00308	CcSEcCtD
Solifenacin—Cystitis—Epirubicin—uterine cancer	0.0022	0.00306	CcSEcCtD
Solifenacin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00305	CcSEcCtD
Solifenacin—Hepatobiliary disease—Etoposide—uterine cancer	0.00215	0.00299	CcSEcCtD
Solifenacin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00294	CcSEcCtD
Solifenacin—Hepatocellular injury—Doxorubicin—uterine cancer	0.00211	0.00293	CcSEcCtD
Solifenacin—Dry eye—Epirubicin—uterine cancer	0.0021	0.00293	CcSEcCtD
Solifenacin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00292	CcSEcCtD
Solifenacin—Hypersensitivity—Progesterone—uterine cancer	0.00209	0.0029	CcSEcCtD
Solifenacin—Hyperkalaemia—Doxorubicin—uterine cancer	0.00207	0.00288	CcSEcCtD
Solifenacin—Bladder pain—Epirubicin—uterine cancer	0.00206	0.00286	CcSEcCtD
Solifenacin—Cystitis noninfective—Doxorubicin—uterine cancer	0.00206	0.00286	CcSEcCtD
Solifenacin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00284	CcSEcCtD
Solifenacin—Cystitis—Doxorubicin—uterine cancer	0.00203	0.00283	CcSEcCtD
Solifenacin—Asthenia—Progesterone—uterine cancer	0.00203	0.00283	CcSEcCtD
Solifenacin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.00282	CcSEcCtD
Solifenacin—Urinary tract disorder—Etoposide—uterine cancer	0.00201	0.0028	CcSEcCtD
Solifenacin—Pruritus—Progesterone—uterine cancer	0.002	0.00279	CcSEcCtD
Solifenacin—Urethral disorder—Etoposide—uterine cancer	0.002	0.00278	CcSEcCtD
Solifenacin—Infection—Dactinomycin—uterine cancer	0.00199	0.00277	CcSEcCtD
Solifenacin—Dry eye—Doxorubicin—uterine cancer	0.00194	0.00271	CcSEcCtD
Solifenacin—Erythema multiforme—Etoposide—uterine cancer	0.00193	0.00268	CcSEcCtD
Solifenacin—Eye disorder—Etoposide—uterine cancer	0.00191	0.00265	CcSEcCtD
Solifenacin—Bladder pain—Doxorubicin—uterine cancer	0.0019	0.00265	CcSEcCtD
Solifenacin—Cardiac disorder—Etoposide—uterine cancer	0.00189	0.00263	CcSEcCtD
Solifenacin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00263	CcSEcCtD
Solifenacin—Dizziness—Progesterone—uterine cancer	0.00187	0.00261	CcSEcCtD
Solifenacin—Angiopathy—Etoposide—uterine cancer	0.00185	0.00257	CcSEcCtD
Solifenacin—Immune system disorder—Etoposide—uterine cancer	0.00184	0.00256	CcSEcCtD
Solifenacin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00256	CcSEcCtD
Solifenacin—Mediastinal disorder—Etoposide—uterine cancer	0.00184	0.00256	CcSEcCtD
Solifenacin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00253	CcSEcCtD
Solifenacin—Vomiting—Progesterone—uterine cancer	0.0018	0.00251	CcSEcCtD
Solifenacin—Rash—Progesterone—uterine cancer	0.00179	0.00248	CcSEcCtD
Solifenacin—Dermatitis—Progesterone—uterine cancer	0.00178	0.00248	CcSEcCtD
Solifenacin—Headache—Progesterone—uterine cancer	0.00177	0.00247	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00175	0.00244	CcSEcCtD
Solifenacin—Decreased appetite—Dactinomycin—uterine cancer	0.00174	0.00242	CcSEcCtD
Solifenacin—Dysgeusia—Etoposide—uterine cancer	0.00174	0.00242	CcSEcCtD
Solifenacin—Renal impairment—Epirubicin—uterine cancer	0.00174	0.00242	CcSEcCtD
Solifenacin—Fatigue—Dactinomycin—uterine cancer	0.00173	0.0024	CcSEcCtD
Solifenacin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00236	CcSEcCtD
Solifenacin—Nausea—Progesterone—uterine cancer	0.00168	0.00234	CcSEcCtD
Solifenacin—Feeling abnormal—Dactinomycin—uterine cancer	0.00165	0.0023	CcSEcCtD
Solifenacin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00164	0.00228	CcSEcCtD
Solifenacin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00227	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00162	0.00225	CcSEcCtD
Solifenacin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00225	CcSEcCtD
Solifenacin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00225	CcSEcCtD
Solifenacin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00224	CcSEcCtD
Solifenacin—Renal impairment—Doxorubicin—uterine cancer	0.00161	0.00224	CcSEcCtD
Solifenacin—Abdominal pain—Dactinomycin—uterine cancer	0.00158	0.0022	CcSEcCtD
Solifenacin—Cough—Etoposide—uterine cancer	0.00155	0.00216	CcSEcCtD
Solifenacin—Hypertension—Etoposide—uterine cancer	0.00153	0.00213	CcSEcCtD
Solifenacin—Liver function test abnormal—Epirubicin—uterine cancer	0.00152	0.00212	CcSEcCtD
Solifenacin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00212	CcSEcCtD
Solifenacin—Dry skin—Epirubicin—uterine cancer	0.00151	0.00211	CcSEcCtD
Solifenacin—Abdominal pain upper—Epirubicin—uterine cancer	0.00151	0.0021	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.0015	0.00209	CcSEcCtD
Solifenacin—Hypersensitivity—Dactinomycin—uterine cancer	0.00147	0.00205	CcSEcCtD
Solifenacin—Confusional state—Etoposide—uterine cancer	0.00146	0.00203	CcSEcCtD
Solifenacin—Muscular weakness—Epirubicin—uterine cancer	0.00146	0.00203	CcSEcCtD
Solifenacin—Anaphylactic shock—Etoposide—uterine cancer	0.00145	0.00202	CcSEcCtD
Solifenacin—Infection—Etoposide—uterine cancer	0.00144	0.002	CcSEcCtD
Solifenacin—Asthenia—Dactinomycin—uterine cancer	0.00144	0.002	CcSEcCtD
Solifenacin—Influenza—Epirubicin—uterine cancer	0.00143	0.00199	CcSEcCtD
Solifenacin—Tachycardia—Etoposide—uterine cancer	0.00141	0.00197	CcSEcCtD
Solifenacin—Liver function test abnormal—Doxorubicin—uterine cancer	0.00141	0.00196	CcSEcCtD
Solifenacin—Skin disorder—Etoposide—uterine cancer	0.00141	0.00196	CcSEcCtD
Solifenacin—Dry skin—Doxorubicin—uterine cancer	0.0014	0.00195	CcSEcCtD
Solifenacin—Abdominal pain upper—Doxorubicin—uterine cancer	0.0014	0.00194	CcSEcCtD
Solifenacin—Muscular weakness—Doxorubicin—uterine cancer	0.00135	0.00188	CcSEcCtD
Solifenacin—Dysuria—Epirubicin—uterine cancer	0.00133	0.00186	CcSEcCtD
Solifenacin—Influenza—Doxorubicin—uterine cancer	0.00132	0.00184	CcSEcCtD
Solifenacin—Somnolence—Etoposide—uterine cancer	0.00129	0.00179	CcSEcCtD
Solifenacin—Infestation—Epirubicin—uterine cancer	0.00127	0.00177	CcSEcCtD
Solifenacin—Infestation NOS—Epirubicin—uterine cancer	0.00127	0.00177	CcSEcCtD
Solifenacin—Vomiting—Dactinomycin—uterine cancer	0.00127	0.00177	CcSEcCtD
Solifenacin—Rash—Dactinomycin—uterine cancer	0.00126	0.00176	CcSEcCtD
Solifenacin—Decreased appetite—Etoposide—uterine cancer	0.00126	0.00175	CcSEcCtD
Solifenacin—Renal failure—Epirubicin—uterine cancer	0.00125	0.00174	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Etoposide—uterine cancer	0.00125	0.00174	CcSEcCtD
Solifenacin—Fatigue—Etoposide—uterine cancer	0.00125	0.00174	CcSEcCtD
Solifenacin—Constipation—Etoposide—uterine cancer	0.00124	0.00172	CcSEcCtD
Solifenacin—Urinary tract infection—Epirubicin—uterine cancer	0.00124	0.00172	CcSEcCtD
Solifenacin—Dysuria—Doxorubicin—uterine cancer	0.00124	0.00172	CcSEcCtD
Solifenacin—Hepatobiliary disease—Epirubicin—uterine cancer	0.0012	0.00168	CcSEcCtD
Solifenacin—Feeling abnormal—Etoposide—uterine cancer	0.00119	0.00166	CcSEcCtD
Solifenacin—Nausea—Dactinomycin—uterine cancer	0.00119	0.00165	CcSEcCtD
Solifenacin—Gastrointestinal pain—Etoposide—uterine cancer	0.00118	0.00165	CcSEcCtD
Solifenacin—Infestation NOS—Doxorubicin—uterine cancer	0.00118	0.00164	CcSEcCtD
Solifenacin—Infestation—Doxorubicin—uterine cancer	0.00118	0.00164	CcSEcCtD
Solifenacin—Renal failure—Doxorubicin—uterine cancer	0.00116	0.00161	CcSEcCtD
Solifenacin—Urticaria—Etoposide—uterine cancer	0.00115	0.0016	CcSEcCtD
Solifenacin—Abdominal pain—Etoposide—uterine cancer	0.00114	0.00159	CcSEcCtD
Solifenacin—Urinary tract infection—Doxorubicin—uterine cancer	0.00114	0.00159	CcSEcCtD
Solifenacin—Pharyngitis—Epirubicin—uterine cancer	0.00113	0.00158	CcSEcCtD
Solifenacin—Urinary tract disorder—Epirubicin—uterine cancer	0.00113	0.00157	CcSEcCtD
Solifenacin—Oedema peripheral—Epirubicin—uterine cancer	0.00113	0.00157	CcSEcCtD
Solifenacin—Connective tissue disorder—Epirubicin—uterine cancer	0.00112	0.00156	CcSEcCtD
Solifenacin—Urethral disorder—Epirubicin—uterine cancer	0.00112	0.00156	CcSEcCtD
Solifenacin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00111	0.00155	CcSEcCtD
Solifenacin—Erythema multiforme—Epirubicin—uterine cancer	0.00108	0.0015	CcSEcCtD
Solifenacin—Eye disorder—Epirubicin—uterine cancer	0.00107	0.00149	CcSEcCtD
Solifenacin—Hypersensitivity—Etoposide—uterine cancer	0.00107	0.00149	CcSEcCtD
Solifenacin—Cardiac disorder—Epirubicin—uterine cancer	0.00106	0.00148	CcSEcCtD
Solifenacin—Pharyngitis—Doxorubicin—uterine cancer	0.00105	0.00146	CcSEcCtD
Solifenacin—Urinary tract disorder—Doxorubicin—uterine cancer	0.00104	0.00145	CcSEcCtD
Solifenacin—Oedema peripheral—Doxorubicin—uterine cancer	0.00104	0.00145	CcSEcCtD
Solifenacin—Asthenia—Etoposide—uterine cancer	0.00104	0.00145	CcSEcCtD
Solifenacin—Connective tissue disorder—Doxorubicin—uterine cancer	0.00104	0.00145	CcSEcCtD
Solifenacin—Angiopathy—Epirubicin—uterine cancer	0.00104	0.00144	CcSEcCtD
Solifenacin—Urethral disorder—Doxorubicin—uterine cancer	0.00104	0.00144	CcSEcCtD
Solifenacin—Immune system disorder—Epirubicin—uterine cancer	0.00103	0.00144	CcSEcCtD
Solifenacin—Mediastinal disorder—Epirubicin—uterine cancer	0.00103	0.00143	CcSEcCtD
Solifenacin—Pruritus—Etoposide—uterine cancer	0.00102	0.00143	CcSEcCtD
Solifenacin—Mental disorder—Epirubicin—uterine cancer	0.001	0.00139	CcSEcCtD
Solifenacin—Erythema multiforme—Doxorubicin—uterine cancer	0.001	0.00139	CcSEcCtD
Solifenacin—Malnutrition—Epirubicin—uterine cancer	0.000995	0.00138	CcSEcCtD
Solifenacin—Eye disorder—Doxorubicin—uterine cancer	0.000988	0.00138	CcSEcCtD
Solifenacin—Cardiac disorder—Doxorubicin—uterine cancer	0.000981	0.00137	CcSEcCtD
Solifenacin—Dysgeusia—Epirubicin—uterine cancer	0.000974	0.00136	CcSEcCtD
Solifenacin—Angiopathy—Doxorubicin—uterine cancer	0.000959	0.00134	CcSEcCtD
Solifenacin—Dizziness—Etoposide—uterine cancer	0.000958	0.00133	CcSEcCtD
Solifenacin—Immune system disorder—Doxorubicin—uterine cancer	0.000955	0.00133	CcSEcCtD
Solifenacin—Mediastinal disorder—Doxorubicin—uterine cancer	0.000953	0.00133	CcSEcCtD
Solifenacin—Vision blurred—Epirubicin—uterine cancer	0.000937	0.0013	CcSEcCtD
Solifenacin—Mental disorder—Doxorubicin—uterine cancer	0.000926	0.00129	CcSEcCtD
Solifenacin—Vomiting—Etoposide—uterine cancer	0.000921	0.00128	CcSEcCtD
Solifenacin—Malnutrition—Doxorubicin—uterine cancer	0.00092	0.00128	CcSEcCtD
Solifenacin—Rash—Etoposide—uterine cancer	0.000913	0.00127	CcSEcCtD
Solifenacin—Dermatitis—Etoposide—uterine cancer	0.000912	0.00127	CcSEcCtD
Solifenacin—Headache—Etoposide—uterine cancer	0.000907	0.00126	CcSEcCtD
Solifenacin—Dysgeusia—Doxorubicin—uterine cancer	0.000901	0.00125	CcSEcCtD
Solifenacin—Palpitations—Epirubicin—uterine cancer	0.000879	0.00122	CcSEcCtD
Solifenacin—Cough—Epirubicin—uterine cancer	0.000868	0.00121	CcSEcCtD
Solifenacin—Vision blurred—Doxorubicin—uterine cancer	0.000867	0.00121	CcSEcCtD
Solifenacin—Nausea—Etoposide—uterine cancer	0.00086	0.0012	CcSEcCtD
Solifenacin—Hypertension—Epirubicin—uterine cancer	0.000859	0.0012	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000841	0.00117	CcSEcCtD
Solifenacin—Dry mouth—Epirubicin—uterine cancer	0.000828	0.00115	CcSEcCtD
Solifenacin—Confusional state—Epirubicin—uterine cancer	0.000819	0.00114	CcSEcCtD
Solifenacin—Palpitations—Doxorubicin—uterine cancer	0.000813	0.00113	CcSEcCtD
Solifenacin—Anaphylactic shock—Epirubicin—uterine cancer	0.000812	0.00113	CcSEcCtD
Solifenacin—Infection—Epirubicin—uterine cancer	0.000807	0.00112	CcSEcCtD
Solifenacin—Cough—Doxorubicin—uterine cancer	0.000803	0.00112	CcSEcCtD
Solifenacin—Nervous system disorder—Epirubicin—uterine cancer	0.000796	0.00111	CcSEcCtD
Solifenacin—Hypertension—Doxorubicin—uterine cancer	0.000795	0.00111	CcSEcCtD
Solifenacin—Tachycardia—Epirubicin—uterine cancer	0.000792	0.0011	CcSEcCtD
Solifenacin—Skin disorder—Epirubicin—uterine cancer	0.000789	0.0011	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000778	0.00108	CcSEcCtD
Solifenacin—Dry mouth—Doxorubicin—uterine cancer	0.000766	0.00107	CcSEcCtD
Solifenacin—Confusional state—Doxorubicin—uterine cancer	0.000757	0.00105	CcSEcCtD
Solifenacin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000751	0.00105	CcSEcCtD
Solifenacin—Infection—Doxorubicin—uterine cancer	0.000746	0.00104	CcSEcCtD
Solifenacin—Nervous system disorder—Doxorubicin—uterine cancer	0.000737	0.00103	CcSEcCtD
Solifenacin—Tachycardia—Doxorubicin—uterine cancer	0.000733	0.00102	CcSEcCtD
Solifenacin—Skin disorder—Doxorubicin—uterine cancer	0.00073	0.00102	CcSEcCtD
Solifenacin—Somnolence—Epirubicin—uterine cancer	0.000722	0.001	CcSEcCtD
Solifenacin—Dyspepsia—Epirubicin—uterine cancer	0.000715	0.000995	CcSEcCtD
Solifenacin—Decreased appetite—Epirubicin—uterine cancer	0.000706	0.000982	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000701	0.000975	CcSEcCtD
Solifenacin—Fatigue—Epirubicin—uterine cancer	0.0007	0.000974	CcSEcCtD
Solifenacin—Constipation—Epirubicin—uterine cancer	0.000694	0.000966	CcSEcCtD
Solifenacin—Feeling abnormal—Epirubicin—uterine cancer	0.000669	0.000931	CcSEcCtD
Solifenacin—Somnolence—Doxorubicin—uterine cancer	0.000668	0.000929	CcSEcCtD
Solifenacin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000664	0.000924	CcSEcCtD
Solifenacin—Dyspepsia—Doxorubicin—uterine cancer	0.000661	0.00092	CcSEcCtD
Solifenacin—Decreased appetite—Doxorubicin—uterine cancer	0.000653	0.000909	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000649	0.000903	CcSEcCtD
Solifenacin—Fatigue—Doxorubicin—uterine cancer	0.000648	0.000901	CcSEcCtD
Solifenacin—Urticaria—Epirubicin—uterine cancer	0.000645	0.000898	CcSEcCtD
Solifenacin—Constipation—Doxorubicin—uterine cancer	0.000642	0.000894	CcSEcCtD
Solifenacin—Abdominal pain—Epirubicin—uterine cancer	0.000642	0.000893	CcSEcCtD
Solifenacin—Feeling abnormal—Doxorubicin—uterine cancer	0.000619	0.000862	CcSEcCtD
Solifenacin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000614	0.000855	CcSEcCtD
Solifenacin—Hypersensitivity—Epirubicin—uterine cancer	0.000598	0.000832	CcSEcCtD
Solifenacin—Urticaria—Doxorubicin—uterine cancer	0.000597	0.000831	CcSEcCtD
Solifenacin—Abdominal pain—Doxorubicin—uterine cancer	0.000594	0.000826	CcSEcCtD
Solifenacin—Asthenia—Epirubicin—uterine cancer	0.000582	0.000811	CcSEcCtD
Solifenacin—Pruritus—Epirubicin—uterine cancer	0.000574	0.000799	CcSEcCtD
Solifenacin—Hypersensitivity—Doxorubicin—uterine cancer	0.000553	0.00077	CcSEcCtD
Solifenacin—Asthenia—Doxorubicin—uterine cancer	0.000539	0.00075	CcSEcCtD
Solifenacin—Dizziness—Epirubicin—uterine cancer	0.000537	0.000747	CcSEcCtD
Solifenacin—Pruritus—Doxorubicin—uterine cancer	0.000531	0.00074	CcSEcCtD
Solifenacin—Vomiting—Epirubicin—uterine cancer	0.000516	0.000718	CcSEcCtD
Solifenacin—Rash—Epirubicin—uterine cancer	0.000512	0.000712	CcSEcCtD
Solifenacin—Dermatitis—Epirubicin—uterine cancer	0.000511	0.000712	CcSEcCtD
Solifenacin—Headache—Epirubicin—uterine cancer	0.000509	0.000708	CcSEcCtD
Solifenacin—Dizziness—Doxorubicin—uterine cancer	0.000497	0.000691	CcSEcCtD
Solifenacin—Nausea—Epirubicin—uterine cancer	0.000482	0.000671	CcSEcCtD
Solifenacin—Vomiting—Doxorubicin—uterine cancer	0.000478	0.000665	CcSEcCtD
Solifenacin—Rash—Doxorubicin—uterine cancer	0.000474	0.000659	CcSEcCtD
Solifenacin—Dermatitis—Doxorubicin—uterine cancer	0.000473	0.000659	CcSEcCtD
Solifenacin—Headache—Doxorubicin—uterine cancer	0.000471	0.000655	CcSEcCtD
Solifenacin—Nausea—Doxorubicin—uterine cancer	0.000446	0.000621	CcSEcCtD
